BIONET Corp. (1784.TWO)

TWD 68.7

(0.15%)

Operating Income Summary of BIONET Corp.

  • BIONET Corp.'s latest annual operating income in 2023 was 84.69 Million TWD , up 47.34% from previous year.
  • BIONET Corp.'s latest quarterly operating income in 2024 Q2 was 26.07 Million TWD , down -48.58% from previous quarter.
  • BIONET Corp. reported an annual operating income of 74.04 Million TWD in 2022, up 76.7% from previous year.
  • BIONET Corp. reported an annual operating income of 41.9 Million TWD in 2021, up 453.95% from previous year.
  • BIONET Corp. reported a quarterly operating income of 26.07 Million TWD for 2024 Q2, down -48.58% from previous quarter.
  • BIONET Corp. reported a quarterly operating income of 7.59 Million TWD for 2023 Q4, down -67.22% from previous quarter.

Annual Operating Income Chart of BIONET Corp. (2023 - 2019)

Historical Annual Operating Income of BIONET Corp. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 84.69 Million TWD 47.34%
2022 74.04 Million TWD 76.7%
2021 41.9 Million TWD 453.95%
2020 7.56 Million TWD -7.63%
2019 8.18 Million TWD 0.0%

Peer Operating Income Comparison of BIONET Corp.

Name Operating Income Operating Income Difference
DIVA Laboratories, Ltd. 92.15 Million TWD 8.094%
Genetics Generation Advancement Corp. 18.57 Million TWD -355.927%
Welgene Biotech Co.,Ltd. -4.25 Million TWD 2088.565%
Puriblood Medical Co., Ltd. -50.4 Million TWD 268.032%
TFBS Bioscience Inc. -4.45 Million TWD 2001.931%